Instructions for authors
Thank you for choosing to submit your paper to us. These instructions will ensure we have everything required so your paper can move through peer review, production and publication smoothly. Please take the time to read and follow them as closely as possible, as doing so will ensure your paper matches the journal's requirements.
This journal uses OJS System for online manuscript submission, manuscript tracking and publishing. You can check, review, correct and track your manuscript to by Register online to the IJDRA journal website, this also helps in peer review manuscript submissions. Please read the “Submission” and this Author Guidelines before making a submission. Complete guidelines for preparing and submitting your manuscript to this journal are provided below:
International Journal of Drug Regulatory Affairs is an international, peer-reviewed journal publishing high-quality, original research. Please see the journal's Aims & Scope for information about its focus and Policies for peer-review policy.
Please note that this journal only publishes manuscripts in English.
International Journal of Drug Regulatory Affairs (IJDRA) accepts the following types of article:
Original Article, Review Articles and Case studies.
IJDRA is committed to peer-review integrity and upholding the highest standards of review. Once your paper has been assessed for suitability by the editor, it will then be double blind peer reviewed by independent, anonymous expert referees. Find out more about what to expect during peer review and read our guidance on publishing ethics.
All authors submitting to Pharmacy journals should conform to the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, prepared by the International Committee of Medical Journal Editors (ICMJE).
International Journal of Drug Regulatory Affairs (IJDRA) publishes Reviews, Research papers, Case study and Short communications/Technical notes. Manuscripts will be reviewed by members of the editorial board, whose opinions will form the basis of the final decision by the editor. It is recommended that an English check of the manuscript by a competent and knowledgeable native speaker be completed before submission. Failure to follow them may result in papers being delayed or rejected.
All submitted manuscripts should contain original work neither published previously not under consideration for publication elsewhere. Authors should check Plagiarism in their Article title and work prior to proceed for submission. Authors should consider the References of last 10 years only in support of their Article, they can use few old references but it should have strong relevance in support of their original work. Articles from any part of the world are accepted provided submitted in English language only. It is necessary that authors prepare their manuscripts according to the instructions. Effectiveness of the peer review process will greatly depends upon the care used by the authors in preparing the manuscripts.
Plagiarism: Original Research should be allowed to publish in the IJDRA Journal.
Manuscripts are accepted on the understanding that the authors have obtained the necessary authority for publication. Manuscripts with multi-authors imply the consent of each of the authors. The publisher will presume that the corresponding author has specifically obtained the approval of all other co-authors to submit the article to IJDRA. Submission of an article to IJDRA is understood to imply that it has not been either published or not being considered for publication elsewhere. Manuscripts should be neatly typed, single lines spaced throughout, including tables, on pages of uniform size. On acceptance authors are asked to fill the copyright transfer form that is available on journal’s web site.
Please note that International Journal of Drug Regulatory Affairs (IJDRA) uses Crossref™ to screen papers for unoriginal material. By submitting your paper IJDRA you are agreeing to originality checks during the peer-review and production processes.
On acceptance, we recommend that you keep a copy of your Accepted Manuscript. Find out more about sharing your work as below:
How to post your article on websites or repositories (Green open access)
Author’s Original Manuscript (AOM)
The AOM is your original manuscript (often called a “preprint”). You can share this as much as you like. If you do decide to post it anywhere, including on a scholarly collaboration network, we would recommend you use an amended version of the wording below to encourage usage and citation of your final, published article (the Version of Record).
Accepted Manuscript (AM)
You can post your Accepted Manuscript (AM) on your personal website at any point after publication of your article (this includes posting to Facebook, Google groups, and LinkedIn plus linking from Twitter). To encourage citation of your work (and be able to monitor and understand who is reading it using article metrics), we recommend that you insert a link from your posted AM to the published article on IJDRA with the following text:
“This is an Accepted Manuscript of an article published by International Journal of Drug Regulatory Affairs (IJDRA) on [date of publication], available online: http://www.ijdra.com/”
N.B. Using a DOI will form a link to the Version of Record on IJDRA Online.
The AM is defined by the National Information Standards Organization as:
“The version of a journal article that has been accepted for publication in a journal.”
This means the version that has been through peer review and been accepted by a journal editor. When you receive the acceptance email from the Editorial Office, keep a copy of your AM for any future posting.
Manuscript can be submitted online after Register in IJDRA.
Any Queries/Suggestion contact via Email: firstname.lastname@example.org
Research Article: Research papers should contain unpublished results of original research, which must be presented in sufficient detail to ensure the reproducibility of the described experiments and should present new experimental studies in elaborate form that constitute a significant contribution to knowledge. They may be up to 5-25 pages.
Review Article: Review articles are concise and critical surveys of novel accomplishments in the author's research field and should bring up the most important current topics or present interpretative and critical accounts, but not simple compilation, on subjects of general interest. The work need not be complete; however, supporting experimental data must be described. They should be around 5-30 pages.
Case Study: A case study describes a typical situation or problem. It is a written account, ideally from the decision-maker's point of view, of an undertaking as it actually occurred. The outcome of the situation described should generally be measured against selected criteria or benchmarks, and its presentation should contribute in one way or another to best practices and excellence. Finally, case studies offer an opportunity to relate real experience to the principles and practices of Pharmacy. In general, they should be around 3-8 pages.
Research Article and Review article:
- Research Article should be written with the following elements in the following order: Title page; Abstract; Keywords; Introduction, Materials and methods, Results, Discussion; Acknowledgments; Financialdisclosure statement, Conflicts of interest, & References.
- Review article and Case studies: not contains materials and methods and results other heading are same as above.
- Should include of tables, references, and figure captions.
- Should contain an abstract of 150 to 250 words.
- Between 5 and 10 keywords that is making your article more discoverable, including information on choosing a title and search engine optimization.
Papers may be submitted in Word format. To assist you in preparing your paper, we provide formatting template(s).
Word templates are available upon request for this journal. Please save the template to your hard drive, ready for use.
If you have any other template queries, please contact us here.
File Formats: Submit MS word files, with Figure, Photos, Graphs, and/ tables electronically embedded within the text of the document with A4 page and 0.7'' margins (On Top, Bottom, Inside & outside).
Please use British (-ise) spelling style consistently throughout your manuscript.
Manuscript Title: Top of paper, Times New Roman; Font style bold, 14 points.
Author Names: Last name, followed full first name, corresponding author of the manuscript must be marked with an asterisk (*) and listed below manuscript Title, Times New Roman; Font style bold, 11 points.
Institution Name: Institution name & addresses Times New Roman, 9 points, Font style Italic.
Times New Roman, 9 points font size, font style Regular with single line spacing.
Research & Reviews articles should include structured abstracts of 150 to 250 words.
Research Article: Objective(s), Design, Intervention(s), Main outcome measure(s), Results, Conclusion, Keywords.
Case Study: About 100 words, Introduction, Case description, Discussion and Evaluation, Conclusions, Keywords.
Reviews Article: Objective(s), Data sources Study selection, summary of contents of the article, Conclusion, Keywords.
Justified, Times New Roman, 10 points font size, font style Regular, text of the document with single line spacing. Use 0 point spacing Before & 6 points after Paragraph. Indentation Right first line by 0.25".
Research Article: This should be presented in Heading: Introduction, Objective(s), Materials & Methods, Results, Discussion, and Conclusion.
Provide a context or background for the study. Explain the objective of research, or hypothesis used. Provide literature with references related to your research. Provide only directly pertinent references, and do not include data or conclusions from the work being reported.
Material and methods
The Methods section should include only information that was available at the time the plan or protocol for the study was being written; all information obtained during the study belongs in the Results section. Author should provide appropriate reference for every method used in research work.
Result and discussion
Present your results in logical sequence in the text, tables, and illustrations, giving the main or most important findings first. Do not repeat all the data in the tables or illustrations in the text; emphasize or summarize only the most important observations. When data are summarized in the Results section, give numeric results not only as derivatives (for example, percentages) but also as the absolute numbers from which the derivatives were calculated, and specify the statistical methods used to analyze them. Use graphs as an alternative to tables with many entries; do not duplicate data in graphs and tables.
Emphasize the novel and important aspects of the study and the conclusions that follow from them in the context of the totality of the best available evidence. Do not repeat in detail data or other information given in the Introduction or the Results section. For experimental studies, it is useful to begin the discussion by briefly summarizing the main findings, then explore possible mechanisms or explanations for these findings, compare and contrast the results with other relevant studies, state the limitations of the study, and explore the implications of the findings for future research and for clinical practice.
Link the conclusions with the goals of the study but avoid unqualified statements and conclusions not adequately supported by the data. Avoid claiming priority or alluding to work that has not been completed.
States new hypotheses when warranted but label them clearly as such.
Tables, Graphs and figures: Should be appropriately inserted within text.
Contributors who do not meet the criteria for authorship should be listed under acknowledgments along with a description of their specific contributions. Examples include individuals providing technical or writing assistance, or a department chair providing general support.
Conflicts of Interest
Authors should disclose any personal or financial relationships that could be viewed as potential conflicts of interest in relation to the publication on manuscript file just before references section.
Please use Vancouver style in-text citations and a Reference List at the end of your document. Citations within the text of your paper are identified with a number in round brackets.
Also we request you to use the contents from already published IJDRA articles and use their references and cite them in your article. This may help you as you can find the reference material from same IJDRA website.
Please crosscheck your reference during your article preparation, as they should be working at the time of access the website or online references.
An EndNote output style is also available to assist you.
- Author details. Please ensure everyone meeting the International Committee of Medical Journal Editors (ICMJE) requirements for authorship is included as an author of your paper. All authors of a manuscript should include their full name and affiliation on the cover page of the manuscript. Where available, please also include ORCiDs. One author will need to be identified as the corresponding author, with their Phone no. and email address normally displayed in the online article. Authors’ affiliations are the affiliations where the research was conducted. If any of the named co-authors moves affiliation during the peer-review process, the new affiliation can be given as a footnote. Please note that no changes to affiliation can be made after your paper is accepted.
- Funding details. Please supply all details required by your funding and grant-awarding bodies as follows:
For single agency grants
This work was supported by the [Funding Agency] under Grant [number xxxx].
For multiple agency grants
This work was supported by the [Funding Agency #1] under Grant [number xxxx]; [Funding Agency #2] under Grant [number xxxx]; and [Funding Agency #3] under Grant [number xxxx].
- Disclosure statement. This is to acknowledge any financial interest or benefit that has arisen from the direct applications of your research. Please include a disclosure statement, using the subheading “Disclosure of interest.” If you have no interests to declare, please state this (suggested wording: The authors report no conflict of interest).
- Data availability statement. If there is a data set associated with the paper, please provide information about where the data supporting the results or analyses presented in the paper can be found. Where applicable, this should include the hyperlink, DOI or other persistent identifier associated with the data set(s).
- Data deposition. If you choose to share or make the data underlying the study open, please deposit your data in a recognized data repository prior to or at the time of submission. You will be asked to provide the DOI, pre-reserved DOI, or other persistent identifier for the data set.
- Figures should be high quality (1200 dpi for line art, 600 dpi for grayscale and 300 dpi for colour, at the correct size). Figures should be supplied in one of our preferred file formats: JPEG, GIF, or Microsoft Word (DOC or DOCX).
- Tables should present new information rather than duplicating what is in the text. Readers should be able to interpret the table without reference to the text. Please supply editable files.
- While sending your manuscript as a Word document, please ensure that equations are editable.
- Please useSI units (non-italicized).
You must obtain the necessary permission to reuse third-party material in your article. The use of short extracts of text and some other types of material is usually permitted, on a limited basis, for the purposes of criticism and review without securing formal permission. If you wish to include any material in your paper for which you do not hold copyright, and which is not covered by this informal agreement, you will need to obtain written permission from the copyright owner prior to submission.
Please ensure that all research reported in submitted papers has been conducted in an ethical and responsible manner, and is in full compliance with all relevant codes of experimentation and legislation. All papers which report in vivo experiments or clinical trials on humans or animals must include a written statement in the Methods section. This should explain that all work was conducted with the formal approval of the local human subject or animal care committees (institutional and national), and that clinical trials have been registered as legislation requires. Authors who do not have formal ethics review committees should include a statement that their study follows the principles of the Declaration of Helsinki.
All authors are required to follow the ICMJE requirements on privacy and informed consent from patients and study participants. Please confirm that any patient, service user, or participant (or that person’s parent or legal guardian) in any research, experiment, or clinical trial described in your paper has given written consent to the inclusion of material pertaining to themselves, that they acknowledge that they cannot be identified via the paper; and that you have fully anonymized them. Where someone is deceased, please ensure you have written consent from the family or estate. Authors may use Patient Consent Form, which should be completed, saved, and sent to the journal if requested.
Please confirm that all mandatory laboratory health and safety procedures have been complied with in the course of conducting any experimental work reported in your paper. Please ensure your paper contains all appropriate warnings on any hazards that may be involved in carrying out the experiments or procedures you have described, or that may be involved in instructions, materials, or formulae.
Please include all relevant safety precautions; and cite any accepted standard or code of practice. When a product has not yet been approved by an appropriate regulatory body for the use described in your paper, please specify this, or that the product is still investigational.
IJDRA journal uses the Basic Data Sharing Policy. Authors are encouraged to share or make open the data supporting the results or analyses presented in their paper where this does not violate the protection of human subjects or other valid privacy or security concerns.
Authors are encouraged to deposit the dataset(s) in a recognized data repository that can mint a persistent digital identifier, preferably a digital object identifier (DOI) and recognizes a long-term preservation plan.
Authors are further encouraged to cite any data sets referenced in the article and provide a Data Availability Statement.
At the point of submission, you will be asked if there is a data set associated with the paper. If you reply yes, you will be asked to provide the DOI, pre-registered DOI, hyperlink, or other persistent identifier associated with the data set(s). If you have selected to provide a pre-registered DOI, please be prepared to share the reviewer URL associated with your data deposit, upon request by reviewers.
Where one or multiple data sets are associated with a manuscript, these are not formally peer reviewed as a part of the journal submission process. It is the author’s responsibility to ensure the soundness of data. Any errors in the data rest solely with the producers of the data set(s).
Please note: As you are submitting your manuscript to IJDRA journal where submissions are double-blind peer reviewed, the main text file should not include any information that might identify the authors (i.e. Author Name, Address, Conflict of Interest and fund related information). As a data availability statement could reveal your identity, we recommend that you remove this from the anonymized version of the manuscript.
There are numerous referencing styles available and each journal’s Instructions for Authors will include information on the recommended style – always check there before referencing data in your article.
Generally, all reference styles will include: a persistent identifier (e.g. DOI) where this is available, the location of the data and the name(s) of the individual(s) responsible for the creation of the data, and the tag “[dataset]”.
There are no submission fees, publication fees or page charges for this journal. There is Article processing charges.
Colour figures will be reproduced in colour in your online article free of charge. If it is necessary for the figures to be reproduced in colour in the print version, a charge will apply.
Charges for colour figures in print version are 20 INR or $10 per figure. Depending on your location, these charges may be subject to local taxes.
On publication, you will be able to view, download and check your article’s metrics (downloads, citations) online from abstract page. This is where you can access every article you have published with us, so you can quickly and easily share your work with friends and colleagues.
We are committed to promoting and increasing the visibility of your article. Here are some tips and ideas on how you can work with us to promote your research.
Ensuring your research makes an impact
Becoming a published author is something worth talking about. Everyone has a list of friends, colleagues, and influential people they’d like to read their work.
As your publisher, we are committed to ensuring your research makes an impact by reaching as wide and diverse an audience as possible. Working in partnership with you means we can achieve an even greater impact. Below are ten tried-and-tested tips for you to try out. All of these will ensure that the right people find, read, and share your published research.Ten tips to maximize the impact of your research
Ten tips to maximize the impact of your research:
- Use your free author eprints: Eprints are a link you can share with up to 50 colleagues and friends, giving them free access to your article. You can share your eprint link in any way you like. Some authors put it at the bottom of their email signature, some email it to 50 people in their contacts list, and some post it on social media (e.g., Twitter or Facebook).
- Include your article in your email signature: Why not include a link to your research in your email signature, alerting everyone you email to your latest article? Many of the people you contact professionally are likely to be working in the same or similar fields as you. This is a quick and easy way to tell them you’re published. If you’d like a banner to add to the bottom of your emails, then just fill out a banner request form and we’ll create one for you.
- Add to your reading lists: Get your students reading and talking about your article. How? Add it, or the journal it’s included in, to your course’s essential reading list.
- Update web pages: Lots of people browsing your institutional and departmental websites? Use this to your advantage by adding a link on your departmental profile page, directing people to your latest article.
- Use social media: Facebook and Twitter are increasingly popular tools amongst researchers. They’re a quick and easy way for researchers to talk about developments in their research field or post about their latest publication. If people start talking about your article, it can increase awareness and readers enormously. It’s also a great way to reach media outlets, with the potential for journalists to pick up on newsworthy research.
- Update your profile on professional and academic networking sites: If you’re on Linkedin, Academia.edu, ResearchGate, Mendeley, or any other professional or academic networking site, you can include links to your article, building a complete picture of your professional expertise and accomplishments. People looking at your profile are already interested in you, and highly likely to click through and read your research. Authors have the opportunity to create a summary PDF for their article, which is ideal for sharing on academic networking sites. Explain what your article is about, why it’s important, and add your own personal perspective on the research.
- Post to discussion lists: It’s easy to post a short message to any discussion lists you are a member of, letting people know that the journal’s latest issue, which includes your article, is now available.
- Tell people on your blog: If you blog, don’t forget to tell your readers about your latest article.
- Put your article in data repositories: Promote your article on Google Scholar etc.
- Speak to your librarian: Check your institution has a subscription to the journal you published in. If not, recommend it for the next subscription year.
You will be sent a link to order article reprints via your account in our production system. For enquiries about reprints, please contact the IJDRA team at email@example.com. You can also order print copies of the journal issue in which your article appears.
Open access publishing proposes a relatively new model for scholarly journal publishing that provides immediate, worldwide, barrier-free access to the full-text of all published articles. Open access allows all interested readers to view, download, print, and redistribute any article without a subscription, enabling far greater distribution of an author's work than the traditional subscription-based publishing model. Many authors in a variety of fields have begun to realize the benefits that open access publishing can provide in terms of increasing the impact of their work.
In an open access model, the publication costs of an article are paid from an author's research budget, or by their supporting institution, in the form of Article Processing Charges. These Article Processing Charges replace subscription charges and allow publishers to make the full-text of every published article freely available to all interested readers. In addition, authors who publish in our open access journals retain the copyright of their work, which is released under a “Creative Commons Attribution License,” enabling the unrestricted use, distribution, and reproduction of an article in any medium, provided that the original work is properly cited.
IJDRA is an open access journal with no Article submission charges, a fee is payable by the author or research funder to cover the costs associated with publication. This ensures your article will be immediately and permanently free to access by everyone.
Publishing an article in this Journal requires Article Processing Charges that will be billed to the submitting author following the acceptance of an article for publication. Apart from these Article Process Charges, there are no submission charges, page charges, or color charges. The fees to be paid following the acceptance of an article are indicated below:
Article Processing Charges (APC) from Authors
Low-Middle Income Countries
Upper-Middle-Income Countries ($)
High-Income Countries ($)
(No other hidden charges)
You can find the list of country as per classification of World Bank. Please read our waiver Process & Policy for more detail.
Once an article has been accepted for publication, any Article Processing Charges on the article become due. The submitting author assumes responsibility for the Article Processing Charges, and IJDRA will not issue refunds of any kind.
IJDRA journal is freely available online, but print editions are available to paying subscribers. All subscription rates in USD are applicable worldwide excluding India for IJDRA journal.
*For Single Issue Order:
For One Calendar Year:
(4 Issues / Year)
* Back issues can be purchased for 500.00 INR per issue if mailed within the India. Discounts are available for authors, as well as for members of IJDRA.
** Foreign Subscribers are required to pay additional shipping costs for print subscriptions.
Subscriptions purchased at the personal rate are strictly for personal, non-commercial use only. The reselling of personal subscriptions is prohibited. Personal subscriptions must be purchased with a personal check, debit or credit card. Proof of personal status may be requested.
Account details to Transfer fees:
Account Name: Jitendra Kumar Badjatya
Account No. 20003834671
Bank Name: State Bank of India
IFSC Code: SBIN0009316
Branch code: 09316
Address: SME Branch, Govind Ashram, I floor, GT Road, Shahdara, Delhi, India-110032.
Modes of Payments: Credit/Debit card/DD/Cheque /Online Banking/Western Union/paytm
Note: It is compulsory to send payment details [i.e. soft copy of cash receipt/ DD details / Cheque Details / Online Transaction/ Paytm/ Western Union (Sender ID Proof copy required)/other mode] to firstname.lastname@example.org
Should you have any queries, please contact us here.